Brief: Cns Pharmaceuticals - Learned Certain Third Parties Distributed Statements, Information Between March 20-May 5 About Wp1122
CNS Pharmaceuticals Inc CNSP.O :
* CNS PHARMACEUTICALS - LEARNED CERTAIN THIRD PARTIES
DISTRIBUTED
STATEMENTS, INFORMATION BETWEEN MARCH 20-MAY 5 ABOUT WP1122
* CNS PHARMACEUTICALS - NEITHER SOLICITED, HAD ADVANCE
KNOWLEDGE
OF, NOR PLAYED ANY ROLE IN PREPARATION OR DISTRIBUTION OF SUCH
THIRD PARTY STATEMENTS
* CNS PHARMACEUTICALS INC - SEC'S SUSPENSION OF TRADING CNS
STOCK
SCHEDULED TO TERMINATE ON MAY 15
Source text for Eikon: ID:nPn5ZMCc1a
Further company coverage: CNSP.O
Recent news on CNS Pharmaceuticals
See all newsCNS Pharmaceuticals Q2 net loss widens, cash rises after financing
CNS Pharmaceuticals Inc expected to post a loss of 24 cents a share - Earnings Preview
NASDAQ RESUMED AT 09:44 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:32 AM
Brief: Cns Pharmaceuticals Appoints Rami Levin As CEO Effective Jan 1, 2026